Sorry, I don't understand. Please try again

Rare autoantibody

Johnson & Johnson is committed to tirelessly pushing the boundaries of research to help develop innovative and transformational approaches to rare autoantibody-driven diseases, building on the ever-evolving understanding of the immune system.

Disease areas

Neuroscience

Chronic inflammatory demyelinating polyneuropathy

Neuroscience

Myasthenia gravis

Rare autoantibody

Warm autoimmune hemolytic anemia

Newsroom

See the latest rare autoantibody news by visiting our newsroom.

Learn more

Featured resources

Our work

What is wAIHA?

In the news

Rare autoantibody diseases: an innovative targeted pathway

Our people

Patient Perspective: Karen Jones on the wAIHA patient experience and a path forward

Our people

Listening and learning: Structuring clinical trials for patients living with warm autoimmune hemolytic anemia

Our work

What is rare disease

Our people

“I couldn’t speak, walk or sit.” Inside dermatomyositis, a rare autoimmune disease that attacks the muscles

Our work

Warm autoimmune hemolytic anemia (wAIHA)